{
  "KL84792_syn_1": "Pt: [REDACTED].\nIndication: Staging RUL Adeno.\nEBUS: Systematic N3->N1.\nSampled: 4R(12mm), 7(18mm), 10R(8mm), 11R(6mm).\nResult: 4R/7 Malignant. 10R/11R Benign.\nComp: None.",
  "KL84792_syn_2": "OPERATIVE REPORT: [REDACTED]-TBNA for staging of a new RUL adenocarcinoma. Under moderate sedation, a systematic review was performed. Transbronchial needle aspiration was conducted at stations 4R, 7, 10R, and 11R. Rapid on-site evaluation confirmed malignancy in the mediastinal stations (4R, 7), while hilar/interlobar stations (10R, 11R) were negative. This confirms N2 disease.",
  "KL84792_syn_3": "CPT: 31653 (EBUS-TBNA 3+ stations).\nStations: 4R, 7, 10R, 11R (4 total).\nFindings: Positive N2 disease (4R, 7).\nAdequacy: ROSE utilized, samples adequate.",
  "KL84792_syn_4": "Procedure: EBUS Staging\nPatient: [REDACTED]\nSteps:\n1. Sedation (Versed/Fent).\n2. EBUS Scope.\n3. Sampled 4R, 7, 10R, 11R.\n4. 4R and 7 positive for cancer.\n5. 10R and 11R negative.\n6. No complications.",
  "KL84792_syn_5": "robert martinez here for staging rul cancer. date 09 15 2024. sedation moderate. procedure systematic ebus tbna. sampled 4r 12mm 4 passes rose pos. 7 18mm 4 passes rose pos. 10r 8mm 3 passes neg. 11r 6mm 3 passes neg. no complications adequate sampling of mediastinum and hilum.",
  "KL84792_syn_6": "Patient: [REDACTED] MRN: [REDACTED] DOB: [REDACTED] Procedure Date: [REDACTED] INDICATION: Mediastinal staging for newly diagnosed right upper lobe lung adenocarcinoma. PET-CT shows FDG-avid mediastinal lymphadenopathy. SEDATION: Moderate sedation achieved with midazolam 3mg IV + fentanyl 75mcg IV. Patient remained Ramsay 3 throughout procedure. Continuous SpO2 monitoring maintained >95%. Blood pressure checked every 5 minutes per protocol. PROCEDURE: Systematic EBUS-TBNA evaluation performed following N3->N2->N1 sequence... [Rest of text]",
  "KL84792_syn_7": "[Indication]\nStaging RUL Adenocarcinoma.\n[Anesthesia]\nModerate sedation.\n[Description]\nSystematic EBUS. Sampled 4 stations: 4R, 7, 10R, 11R. Malignancy confirmed in 4R and 7.\n[Plan]\nOncology follow-up.",
  "KL84792_syn_8": "[REDACTED] for staging of his lung cancer. We did a thorough EBUS exam, checking lymph nodes from the mediastinum out to the lung. We sampled four specific stations: 4R, 7, 10R, and 11R. The biopsy results right there in the room showed cancer in the 4R and 7 nodes, but the 10R and 11R nodes looked clear. He handled the sedation well.",
  "KL84792_syn_9": "Patient: [REDACTED]. INDICATION: Mediastinal staging for newly diagnosed right upper lobe lung adenocarcinoma. PROCEDURE: Systematic EBUS-TBNA evaluation executed following N3->N2->N1 sequence. Stations sampled: Station 4R: 4 needle passes, ROSE positive. Station 7: 4 needle passes, ROSE positive. Station 10R: 3 needle passes, ROSE adequate. Station 11R: 3 needle passes, ROSE adequate. IMPRESSION: EBUS-TBNA with sufficient sampling.",
  "KL84792": "Patient: [REDACTED]  MRN: [REDACTED]  DOB: [REDACTED]\nProcedure Date: [REDACTED]\n\nINDICATION: Mediastinal staging for newly diagnosed right upper lobe lung adenocarcinoma. PET-CT shows FDG-avid mediastinal lymphadenopathy.\n\nSEDATION: Moderate sedation achieved with midazolam 3mg IV + fentanyl 75mcg IV. Patient remained Ramsay 3 throughout procedure. Continuous SpO2 monitoring maintained >95%. Blood pressure checked every 5 minutes per protocol.\n\nPROCEDURE:\nSystematic EBUS-TBNA evaluation performed following N3→N2→N1 sequence. Photodocumentation of all accessible lymph node stations completed prior to sampling.\n\nStations sampled:\n- Station 4R: Short axis 12mm, 4 needle passes, ROSE positive for malignant cells, PET+\n- Station 7: Short axis 18mm, 4 needle passes, ROSE positive for malignant cells, PET+\n- Station 10R: Short axis 8mm, 3 needle passes, ROSE adequate, PET-\n- Station 11R: Short axis 6mm, 3 needle passes, ROSE adequate, PET-\n\nCOMPLICATIONS: None. No bleeding, no desaturation events.\n\nIMPRESSION: EBUS-TBNA with adequate sampling of mediastinal and hilar lymph nodes for complete staging evaluation."
}
